Showing 1 - 10 of 147
The prenatal diagnosis of Down syndrome (amniocentesis) presents parents with a complex dilemma which requires comparing the risk of giving birth to an affected child and the risk of losing an unaffected child through amniocentesis-related miscarriage. Building on the specific features of the...
Persistent link: https://www.econbiz.de/10011193760
In this paper, we want to characterize the optimal health insurance contract with adverse selection and moral hazard. We assume that policyholders differ by the permanent health status loss and choose an unobservable preventive effort in order to reduce the probability of illness which is...
Persistent link: https://www.econbiz.de/10010861415
This paper investigates the impact of health risk on insurance contract with hazard moral. We use a bi-dimensional utility function (wealth and health status). We prove that the type of health risk influences the equilibrium of insurance market. A full coverage is possible with moral hazard....
Persistent link: https://www.econbiz.de/10010861615
Lifelong immunoglobulin replacement is the standard, expensive therapy for severe primary antibody deficiencies. This treatment can be administrated either by intravenous immunoglobulin (IVIG) or subcutaneous infusions (SCIG) and delivered at home or in an out-patient setting. This study aims to...
Persistent link: https://www.econbiz.de/10011072699
Persistent link: https://www.econbiz.de/10010707156
Persistent link: https://www.econbiz.de/10010707914
Persistent link: https://www.econbiz.de/10010708770
We develop a "welfarist" model in which the collective demand for health insurance is mainly explained by a solvability motive : health insurance does not have for principal function to treat the risk aversion of solvent agents but to make it possible to individuals who are too poor to assume...
Persistent link: https://www.econbiz.de/10010708942
Price regulation and competition patterns in the ethical drug industry in france This article gives the results of an econometric modelization of the ethical drugs price and quantity determination institutionnal process for France. From price and promotion elasticities, it is shown that...
Persistent link: https://www.econbiz.de/10011096648
Efficient resources allocation in health area, where market failures are numerous and government regulations very large, is generally considered as requiring the support of cost-benefit, cost-effectiveness or cost-utility studies. Meanwhile many disappointments appear on the effective impact of...
Persistent link: https://www.econbiz.de/10011096662